AVeta Medical appoint Brian Ledwith as their new CEO

AVeta Medical appoint Brian Ledwith as their new CEO

We are delighted to announce that Brian Ledwith, R&D Director of AVeta Medical, has been promoted to the CEO role. Brian brings him a wealth of knowledge from over 20 years working in the med-tech industry, having worked on Fem-tech focused products over the span of his career.

Brian will head the team up as they progress into the next phase of the business, focusing on funding and investment in a bid to safe guard the company for the future and develop their innovative Vaginal Atrophy product to gain FDA clearance and bring the product to production phase. Brians expertise in product development, and pre production requirements will bolster the inevitable development of the product and company.

Paula Newell, Founder, wishes Brian all the best in his new role and will continue to support the company in an advisory consulting capacity, while remaining on the Board of Directors. This is an exciting time for the company as Brian will lead AVeta Medical beyond its current start up phase and into its growth commercialization phase.

Disclaimer: This product is currently under development and has not been approved for sale by the U.S. Food and Drug Administration (FDA) or under the EU Medical Device Regulation (MDR). It is not available for purchase in the United States or the European Union.